IntelliPharmaCeutics International Inc News

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan

Stockhouse Mar 13 17:15 ET

Canadian Investment Regulatory Organization Trading Halt - IPCI

Stockhouse Mar 6 07:51 ET

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form

AccesswireFeb 26 19:38 ET

Intellipharmaceutics International Inc. Announces Stock Option Grant

AccesswireFeb 8 16:35 ET

IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing

MT NewswiresJan 3 06:36 ET

Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange

Stockhouse Jan 2 17:40 ET

IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue

MT NewswiresJul 14, 2023 16:15 ET

Intellipharmaceutics International Inc. Brief: Recorded Net Loss for Q1 of US$355,738 or $0.01 per Common Shar

MT NewswiresJun 6, 2023 06:05 ET

Intellipharmaceutics International Inc. Brief: Announcing Cease Trade Order

MT NewswiresMar 7, 2023 17:16 ET

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest

Financial News LiveJan 19, 2023 10:01 ET

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update

kopsourceDec 4, 2022 10:31 ET

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Significant Drop in Short Interest

Financial News LiveAug 15, 2022 16:21 ET

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Down 37.3% in March

ETF Daily NewsApr 16, 2022 11:02 ET